Ask AI
ProCE Banner Activity

From Target to Tolerability: Nurse-Led Strategies for Optimizing Bispecific Antibody Therapy in Multiple Myeloma

Slideset

Downloadable slides on nurse-led strategies for optimizing bispecific antibody therapy in patients with multiple myeloma based on key clinical evidence.

Released: May 05, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

ProCE Banner

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson

Target Audience

This activity has been designed to meet the educational needs of community oncology nurses, nurse practitioners, and other healthcare professionals caring for patients with multiple myeloma.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate emerging safety and efficacy data on bispecific antibody therapeutics in the treatment of patients with multiple myeloma

  • Identify patients with multiple myeloma who may be eligible for ongoing clinical trials evaluating currently available and emerging bispecific antibodies

  • Manage and mitigate adverse events associated with bispecific antibody treatment in patients with multiple myeloma

  • Educate patients with myeloma and their caregivers on how to identify and mitigate risk and thereby improve outcomes